Header Logo

Connection

Mark Pollack to Mood Disorders

This is a "connection" page, showing publications Mark Pollack has written about Mood Disorders.
Connection Strength

0.483
  1. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
    View in: PubMed
    Score: 0.157
  2. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behav Ther. 2014 Sep; 45(5):619-29.
    View in: PubMed
    Score: 0.120
  3. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008; 14(1):2-9.
    View in: PubMed
    Score: 0.079
  4. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5.
    View in: PubMed
    Score: 0.070
  5. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998 Jan-Feb; 39(1):24-9.
    View in: PubMed
    Score: 0.039
  6. Calcium channel blockers in psychiatry. Psychosomatics. 1987 Jul; 28(7):356-60, 369.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.